Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2021 / Article

Review Article | Open Access

Volume 2021 |Article ID 2731446 | https://doi.org/10.1155/2021/2731446

Haizhen Lu, Chengwen Zheng, Yanmei Zhong, Linhao Cheng, Yi Zhou, "Effectiveness of Acupuncture in the Treatment of Hyperemesis Gravidarum: A Systematic Review and Meta-Analysis", Evidence-Based Complementary and Alternative Medicine, vol. 2021, Article ID 2731446, 14 pages, 2021. https://doi.org/10.1155/2021/2731446

Effectiveness of Acupuncture in the Treatment of Hyperemesis Gravidarum: A Systematic Review and Meta-Analysis

Academic Editor: Yun Jin Kim
Received30 Apr 2021
Accepted15 Jul 2021
Published28 Jul 2021

Abstract

Background. Hyperemesis gravidarum (HG) is a common gastrointestinal disease afflicting gravidas. It usually results in hospital admission in early pregnancy. Objective. Through a meta-analysis, this study intended to explore acupuncture’s clinical efficacy in treating HG. Materials and Methods. A comprehensive search of PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Biological Medical (CBM), Wanfang Database, and China Science and Technology Journal (VIP) for published clinical randomized controlled trials (RCTs) of acupuncture for treating HG was conducted from the date of database creation to 20th January 2021. We also searched grey literature in four databases: Chinese Cochrane Center, Chinese Clinical Trial Registry, GreyNet International, and Open Grey from their inception to 20th January 2021. Two authors independently screened the literature, extracted data, and evaluated the quality of the literature with Cochrane Handbook 5.1.0 and Review Manager 5.2 software. Review Manager 5.2 and STATA 12.0 software were applied to analyze data. Heterogeneity analysis was performed by the Cochran Chi-square test and I2 statistic. Egger’s tests together with funnel plots were used to identify publication bias. Results. A total of 16 trials covering 1043 gravidas were included. Compared with the conventional treatment, acupuncture had a significantly higher effective rate (OR: 8.11, 95% CI: 5.29∼12.43; ), a higher conversion rate of urine ketone (RR: 1.36, 95% CI: 1.15∼1.60; ), an improvement rate of nausea and vomiting (OR: 26.44, 95% CI: 3.54∼197.31; ), and a relatively higher improvement rate of food intake (RR: 1.17, 95% CI: 1.01∼1.36; ). Acupuncture also shortened hospitalization time and manifested with a lower pregnancy termination rate and fewer adverse events. Nevertheless, no statistical variation in the improvement of nausea intensity, vomiting episodes, and lassitude symptom, recurrence rate, and serum potassium was observed. Conclusion. Our study suggested that acupuncture was effective in treating HG. However, as the potential inferior quality and underlying publication bias were found in the included studies, there is a need for more superior-quality RCTs to examine their effectiveness and safety. PROSPERO registration number: CRD42021232187.

1. Introduction

Hyperemesis gravidarum (HG) is generally regarded as severe nausea and vomiting during pregnancy (NVP); presently, there is no consensus definition towards it [1]. HG is generally defined as severe intractable vomiting, weight loss >5%, dehydration, ketonuria, malnutrition, and electrolyte imbalance [2, 3], whose incidence is about 1%. HG is usually responsible for hospitalization in early pregnancy [4], brings about serious physical and mental disorders [57], affects the postpartum period [6, 8], and poses an impact upon the quality of life [9].

At present, the etiology and the pathogenesis of HG are still unclear. According to contemporary medicine, the development of HG is correlated with enhanced human chorionic gonadotropin (HCG) levels, estrogen levels, neurological disorders, vitamin B deficiency, Helicobacter pylori infection [10, 11], weakened gastrointestinal motility, hypofunction of the adrenal cortex and anterior pituitary gland, and thyroid dysfunction, as well as genetics, mental and psychological state, and economic status [1216].

Common clinical treatments involve intravenous rehydration, parenteral nutrition, correction of electrolyte disturbances, vitamin supplements, ginger, antiemetics, dopamine antagonists, serotonin 5-hydroxytryptamine Type 3 (5-HT3) receptor antagonists, Helicobacter pylori treatment, and intramuscular injection of vitamin B6, etc. [1721]. However, due to the unsatisfactory efficacy of conventional treatments, adverse reactions, and teratogenic risks, people resort to complementary and alternative therapies [22].

As a complementary and alternative therapy, acupuncture is under practice for treating HG in many countries [18]. It has achieved certain therapeutic effects by stimulating acupoints. Acupuncture relieves nausea and vomiting to treat HG through the control and coordination of sympathetic and parasympathetic by activating the central structure and may also be pertinent to the regulation of neuroendocrine mechanisms [23]. However, according to guidelines, the effectiveness of acupuncture for HG is still controversial [2426], which may be attributed to its different diagnostic and efficacy standards and lack of high-quality randomized controlled trials (RCTs). Hence, it is necessary to evaluate the efficacy of acupuncture for HG comprehensively and objectively.

Although there are different forms of acupuncture, such as auricular acupuncture, press needle (thumb-tack needle, a method of pressing very short needles into superficial subcutaneous) and hydroacupuncture (acupoint injection, a method of injecting medicine into acupoints), this study only focused on common forms of acupuncture (traditional acupuncture, body acupuncture, manual acupuncture, and electroacupuncture). Our objective is to systematically evaluate the efficacy of acupuncture for treating HG by unifying the inclusion criteria and screening out RCTs with common forms of acupuncture for HG patients, which may provide valuable evidence-based medical solutions for clinical medical performance.

2. Methods

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement guidelines (Table S1) are conformed to in this meta-analysis and system review [27]. There is no systematic review protocol for this study, but we have registered this systematic review on PROSPERO: CRD42021232187.

2.1. Search Strategy

This meta-analysis is a literature review; hence, approval from the institutional review board is not compulsory.

Such databases as PubMed, EMBASE, Cochrane Library, Chinese Biological Medical (CBM), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal (VIP), and Wanfang database were used for the retrieval from their inception to 20th January 2021. Besides, grey literature was retrieved from the Chinese Cochrane Center, Chinese Clinical Trial Registry, GreyNet International, and Open Grey from their inception to 20th January 2021. We retrieved reference works of included studies concomitantly. Chinese search terms include (“针刺” OR “针灸” OR “电针” OR“体针” OR “毫针”) AND (“妊娠剧吐” OR “妊娠恶阻”). The English search strategies including MeSH and text words are as follows, which may be slightly modified based on the requirements of different databases: hyperemesis gravidarum, pernicious vomiting of pregnancy, acupuncture, and acupuncture therapy. The retrieve was performed with the search strategies as the list: (Hyperemesis Gravidarum [MeSH] OR Pernicious Vomiting of Pregnancy [Title/Abstract] OR Pregnancy Pernicious Vomiting [Title/Abstract]) AND (Acupuncture [MeSH] OR Acupuncture Therapy [MeSH] OR Acupuncture Points [MeSH] OR Acupuncture Treatment  [Title/Abstract] OR Electroacupuncture  [Title/Abstract] OR Acupoint  [Title/Abstract]) AND (randomized controlled trial [Publication Type] OR randomized [Title/Abstract] OR placebo [Title/Abstract]) (Table 1). The management of all references was achieved by Endnote X9.2 software.


No.Searches

#1Hyperemesis Gravidarum [MeSH]
#2Pernicious Vomiting of Pregnancy [title/abstract]
#3Pregnancy Pernicious Vomiting [title/abstract]
#4#1 OR #2 OR #3
#5Acupuncture [MeSH]
#6Acupuncture Therapy [MeSH]
#7Acupuncture Points [MeSH]
#8#5 OR #6 OR #7
#9Acupuncture [title/abstract]
#10Acupuncture treatment  [title/abstract]
#11Acupuncture therap  [title/abstract]
#12Pharmacopuncture [title/abstract]
#13Pharmacoacupuncture treat  [title/abstract]
#14Electroacupunctur  [title/abstract]
#15Electro-acupunctur  [title/abstract]
#16Acupoint  [title/abstract]
#17Acupotom  [title/abstract]
#18Point, Acupuncture [title/abstract]
#19Meridian  [title/abstract]
#20Moxibustion [title/abstract]
#21#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20
#22#8 OR #21
#23Randomized controlled trial [publication type]
#24Randomized [title/abstract]
#25Placebo [title/abstract]
#26#23 OR #24 OR #25
#27#4 AND #22 AND #26


Participants (P)Patients diagnosed with HG.

Interventions (I)The treatment group received the common forms of acupuncture solely or combined with other treatments, regardless of acupoint selection, treatment frequency, or course.
The control group adopted conventional symptomatic treatment, conventional medication, placebo, sham, or no treatment.
The two groups could receive the same basic treatment.

Comparisons (C)The control group adopted conventional treatment, medication, placebo acupuncture, sham acupuncture, or no treatment.

Outcomes (O)The effective rate, conversion rate of urine ketone, symptom improvement rate, serum potassium, hospital stay, pregnancy termination rate, adverse events, and recurrence.

Study design (S)RCT.

2.2. Eligibility Criteria
2.2.1. Inclusion Criteria

(1)Type of participants: the subjects are patients diagnosed with HG (diagnosed by a clinician or using any recognized diagnostic criteria), regardless of ethnicity, country, age, and course of the disease.(2)Type of interventions: the treatment group received the common forms of acupuncture solely or combined with other treatments, regardless of acupoint selection, treatment frequency, or course. The control group adopted conventional symptomatic treatment, conventional medication, placebo, sham, or no treatment. The two groups could receive the same basic treatment.(3)Type of comparisons: the control group adopted conventional treatment, medication, placebo acupuncture, sham acupuncture, or no treatment.(4)Type of outcomes: the effective rate, the conversion rate of urine ketone, symptom improvement rate, serum potassium, hospital stay, pregnancy termination rate, adverse events, and recurrence.(5)Type of studies: the study type was confined to RCTs, and the qualified articles were limited to Chinese or English language (Table 2).

2.2.2. Exclusion Criteria

(1)Participants with serious organic diseases or medical diseases that can induce vomiting.(2)The treatment group received traditional Chinese medicine or other forms of acupuncture (such as auricular acupuncture, hydro-acupuncture and press needle). The control group was combined with acupuncture-related therapies.(3)We also excluded trials that simultaneously conducted acupuncture and acupuncture-related therapies (such as acupressure and moxibustion) in the treatment group where the mainstay of the acupuncture could not be identified.(4)Excluded reviews, theoretical discussion, case reports, animal experiments, crossover trials, and non-RCTs.(5)Excluded duplicate publications and studies with incomplete data.

2.3. Outcome Measurements

The results are mainly expressed by the effective rate: the number of cases (cured + markedly effective + improved)/total number of cases × 100%. The secondary outcomes are the conversion rate of urine ketone, symptoms improvement rate (nausea intensity, vomiting episodes, nausea and vomiting, food intake, and lassitude), serum potassium, length of hospital stay, and the rate of pregnancy termination, adverse events, and recurrence.

2.4. Study Selection

All papers were imported into the software Endnote X9.2 for management. Two authors (Haizhen Lu, Chengwen Zheng) independently screened the literature. Endnote X9.2 was used to sort all literature, and two authors manually put the documents with duplicate titles and abstracts into the “duplicate documents” folder for management. After excluding duplicates, by reviewing the title and abstract, studies that did not meet the criteria of the type of studies, participants, interventions, comparisons, and outcomes were removed. And then, studies that met the above eligibility criteria were covered after reviewing the full text. Any problems in the process of selecting the included studies should be resolved through discussion or deliberation with the third author (Yanmei Zhong).

2.5. Data Extraction

Data were extracted independently by two authors (Haizhen Lu, Chengwen Zheng) who checked the extracted data with each other. Any disagreements are resolved through conferencing or consulting with the third author (Yanmei Zhong). Available information was recorded by Microsoft Excel 2010 with standard designed forms, including baseline information (first author, study type, country, publication year, age, gestational age, sample, intervention of the treatment and control group, duration of treatment, and relevant outcomes) and outcomes (effective rate, conversion rate of urine ketone, improvement rate of nausea intensity, vomiting episodes, nausea and vomiting, food intake, and lassitude symptom, serum potassium, length of hospitalization, rate of pregnancy termination, adverse events, and recurrence).

2.6. Bias Risk Assessment

Two authors (Haizhen Lu, Chengwen Zheng) independently evaluated the quality of each study. The Cochrane Handbook 5.1.0 and RevMan 5.2 software were used to evaluate the quality of each of the studies, including bias risk in the following items: random sequence generation; whether to assign hiding; whether to blindly perform blinding to participants and researchers; whether to use blinding for result measurement; whether the outcome data is complete, whether to report selectively; other bias. The risk of bias was ranked as “low,” “high,” or “unclear.” Any problems were resolved through conferencing or consulting with the third author (Yanmei Zhong).

2.7. Data Analysis

The combined risk ratio (RR) and odds ratio (OR) were utilized for evaluating the dichotomous outcomes at the 95% confidence interval (95% CI); the continuous outcomes were represented by the mean difference (MD) of 95% CI. Study heterogeneity was expressed as the Cochran Chi-square test and I2 statistic. I2 > 50% indicated significant heterogeneity. To summarize the results, the random-effects and fixed-effects models were applied, respectively, when I2 > 50% and I2 < 50%. A concomitant sensitivity analysis was performed for identifying the potential origin of inhomogeneity. Then, studies that caused marked inhomogeneity were deleted, and the remaining studies were re-meta-analyzed to adjust. If there is no substantial difference between the results before and after the adjustment, the robustness of our meta-analysis will be confirmed [28]. The conversion of effect mode conducted a sensitivity analysis on outcomes with small heterogeneity to assess whether the result is robust. Egger’s tests together with funnel plots were performed to identify whether there was publication bias. Statistical analysis was conducted by RevMan5.2 and STATA 15.0.

3. Results

3.1. Study Selection

According to the searching strategy, 472 papers were retrieved from the inception of databases to 20th January 2021. And during the search of grey literature, no suitable or valuable literature and information was obtained. After deduplication, a total of 230 records were identified. Then, 147 records were removed after reading titles and abstracts. After reading all the full text, 67 papers out of residual 83 articles were removed from the analysis due to the following reasons: five papers were combined with acupuncture in the control group, seven were combined with traditional Chinese medicine, two used other acupuncture methods, eight articles were not mainly based on acupuncture, one was not in Chinese or English, forty-three papers were not RCTs, and one was with data duplication. In the end, 16 studies were selected to be incorporated in this meta-analysis, as illustrated in Figure 1 [18, 19, 2942].

3.2. Study Characteristics

Overall, 14 studies are in Chinese and two in English. All studies reported comparable or nonsignificant differences in general information such as age and gestation period between intervention groups. Among them, there were one four-arm trial [18] and two three-arm trials [41, 42], and the rest were two-arm trials. The sample size of each group ranged from 8 to 50 cases. The treatment group and the control group involved seven therapeutic methods: acupuncture, acupuncture placebo, moxibustion, acupoint sticking (a method of applying ointments on acupoints), acupressure, intravenous rehydration, and conventional medicine. The shortest duration of treatment was 3 days and the longest was 14 days, but no specific duration was reported in three studies [36, 38, 39]. No follow-up was recorded. Fifteen studies reported the effective rate [18, 2942], 3 studies presented the conversion rate of urinary ketone [29, 30, 40], 1 study mentioned the improvement rate of nausea intensity and vomiting episode [19], 2 studies referred to the improvement rate of nausea and vomiting [30, 40], 3 studies mentioned the improvement of food intake [19, 30, 40], 2 studies were related to improvement rate of lassitude symptom [30, 40], 2 studies evaluated serum potassium [29, 31], 2 studies reported length of hospital stay [29, 35], 2 studies stated pregnancy termination rate [29, 31], 1 study referred to recurrence rate [35], and 1 study mentioned adverse events [38]. Tables 3 and 4 list the included study’s features.


StudyYearCountryStudy periodAge (years) (mean ± SD)Gestational age (weeks) (mean ± SD)
TCTC

Habek et al. [18]2004Croatia20.4 ± 4.720.8 ± 4.17 (6–9)8 (7–12)
Neri et al. [19]2005Italy2001.5–2002.7
Jin and Hu [29]2014China2009.10–2013.1025.09 ± 3.4226.03 ± 3.199.03 ± 2.158.98 ± 2.28
Ma et al. [30]2020China2013.10–2017.1031.14 ± 4.0631.36 ± 4.248.64 ± 1.228.36 ± 1.31
Wang [31]2008China2005.1–2006.127 ± 327 ± 4
Ma and Meng [32]2013China2010–201226.30
Zhao and Qiao [33]2018China2015.4–2017.1126 ± 326 ± 38.33 ± 1.948.03 ± 1.63
Zhang [34]2013China2008.1–2012.1228.58 ± 4.5728.68 ± 3.768.90 ± 1.668.97 ± 1.58
Yan et al. [35]2012China2008.1–2009.628.09 ± 5.7828.03 ± 6.259.08 ± 2.448.95 ± 2.58
Xu et al. [36]2015China2013.1–2014.10(20–35)#(4–12)#
Sun and Cui [37]1995China1992.1–1994.12(22–34)#
Yang [38]2019China2016.11–2018.1131.56 ± 6.2531.42 ± 6.378.52 ± 3.628.86 ± 3.57
Zhong [39]2017China2015.9–2016.928.35 ± 2.7627.93 ± 2.47
Xie [40]2006China2004.1–2005.527.25 ± 3.3527.46 ± 3.29
Mao and Liang [41]2009China2001.1–2008.1228.23 ± 4.7328.63 ± 4.868.30 ± 1.608.33 ± 1.58
Zhang [42]2005China1999.3

Abbreviation: SD: standard deviation; T: treatment group; C: control group; : figures are median and range; #: figures are a range.

StudyInterventionNumber of patients (T/C)Intervention periodRelevant outcomesStudy type
TC

Habek et al. [18]APPlacebo acupuncture18 (10/8)Over 7 daysRCT
Neri et al. [19]AP + acupressureMetoclopramide
Infusion + oral vitamin B12 complex 30 mg/day
81 (43/38)14 days④⑩⑪RCT
Jin and Hu [29]AP + ①40 (20/20)Lasted for 5 days②③⑦⑧⑨RCT
Ma et al. [30]AP + ①72 (35/34)Lasted for 7 days②③④⑤⑥RCT
Wang [31]AP95 (53/42)Lasted for 6 days②⑧⑨RCT
Ma and Meng [32]AP + TNATNA60 (30/30)Lasted for 5 daysRCT
Zhao and Qiao [33]AP + acupoint sticking60 (30/30)Lasted for up to 7 daysRCT
Zhang [34]AP + ① + psychological counseling62 (31/31)Lasted for 7 daysRCT
Yan et al. [35]AP + ①64 (32/32)(3.12 ± 0.25) days/(6.32 ± 0.12) days②⑦⑬RCT
Xu et al. [36]AP + moxibustion + ①70 (35/35)UnknownRCT
Sun and Cui [37]AP + ①40 (20/20)Lasted for 3 daysRCT
Yang [38]AP + ①60 (30/30)Unknown②⑫RCT
Zhong [39]AP + ①70 (35/35)UnknownRCT
Xie [40]AP + ①94 (47/47)Lasted for 10 days②③④⑤⑥RCT
Mao and Liang. [41]AP + ①① + oral luminal 30 mg, tid60 (30/30)Lasted for 7 daysRCT
Zhang [42]AP + moxibustion① + oral luminal 30 mg, tid100 (50/50)14 daysRCT

Abbreviation: T: treatment group; C: control group; RCT: randomized controlled trial; AP: acupuncture; TNA: total nutrient admixture; tid: three times a day; ①: symptomatic rehydration support treatment; ②: effective rate; ③: conversion rate of urine ketone; ④: improvement rate of food intake; ⑤: improvement rate of lassitude symptom; ⑥: improvement rate of nausea and vomiting symptom; ⑦:length of hospital stay; ⑧: serum potassium; ⑨: pregnancy termination rate; ⑩: improvement rate of nausea intensity; ⑪: improvement rate of vomiting episodes; ⑫: adverse events rate; ⑬: recurrence rate.
3.3. Bias Risk Assessment

The trials of 16 studies selected were all randomized controlled. As identified by the corresponding Cochrane tool, all studies mentioned randomization, of which 6 studies [18, 32, 35, 3739] did not report the specific method of randomization, and 4 studies [33, 34, 36, 40] used the higher risk of random methods, such as the order of registration or treatment sequence. And 6 studies [19, 2931, 41, 42] applied the random number table method or computer random number method to generate random sequences. None of the studies mentioned the application of allocation concealment information. As for the blinding method, only one study [40] mentioned “single blinding” but the detailed operation description was absent. No study mentioned evaluator blinding. The bias risk of all trials was rated low regarding outcome completeness. Two studies [31, 32] had selective reports. Other biases were classified as unclear due to insufficient information. In general, included RCTs were of low quality. Figures 2 and 3 summarize the quality evaluation of eligible studies.

3.4. Results of Meta-Analysis
3.4.1. Effective Rate

The effective rate is the main outcome of this study. Fifteen studies [18, 2942] compared the effective rate at the end of treatment. And 15 trials reported data on 962 participants. The between-study I2 statistical heterogeneity was 0%, and the value of the χ2 test was 0.75 (). No marked heterogeneity existed between the studies, so the fixed-effects model was selected for analysis. The results showed that the effective percentage of the acupuncture set was significantly higher than other active treatments in the control group (OR: 8.11, 95% CI: 5.29∼12.43; ). The result of indicated an evident group difference (Figure 4). There was no significant heterogeneity between the studies, so no subgroup analysis was performed

3.4.2. Conversion Rate of Urine Ketone

Three studies [29, 30, 40] compared the conversion rate of urine ketone after treatment with the control group. And 203 participants were included in 3 studies. With no obvious heterogeneity between the studies (, I2 = 0%), the fixed-effects model was employed for analysis. The results implied that, compared with the control group, the conversion rate of urine ketone was higher in the acupuncture group (Figure 5, RR: 1.36, 95% CI: 1.15∼1.60; ). Since , a clear difference between the two groups was present.

3.4.3. Improvement Rate of Nausea Intensity

One study [19] reported an improvement in the nausea intensity after the treatment. The random effect model implied the absence of any statistical difference between the acupuncture set and the conventional medication set in terms of nausea intensity improvement (RR: 1.40, 95% CI: 0.79∼2.49; ). Since , no evident difference could be seen between the two groups.

3.4.4. Improvement Rate of Vomiting Episodes

One study [19] reported an improvement rate of vomiting episodes before and after treatment. The random-effects model revealed the nonexistence of a statistically significant group difference (RR: 1.51, 95% CI: 0.92∼2.48; ).

3.4.5. Improvement Rate of Nausea and Vomiting Symptom

Two studies [30, 40] reported the improvement rate of nausea and vomiting symptoms with 153 participants in total. The heterogeneity test showed good heterogeneity (, I2 = 0%), using fixed-effects model. The combined effect amount results revealed that the improvement rate of nausea and vomiting symptoms in the acupuncture setting is markedly higher than the control set (Figure 6, OR: 26.44, 95% CI: 3.54∼197.31; ). Since , the divergence between both sets was statistically distinct.

3.4.6. Improvement Rate of Food Intake

Three studies [19, 30, 40] reported the improvement rate of food intake after the treatment. A total of 3 trials evaluated 218 enrolled participants. Meta-analysis with stochastic effect mode implied that the improvement rate of food intake was higher in the acupuncture group (Figure 7, RR: 1.35, 95% CI: 1.01∼1.82; ) with a moderate study heterogeneity (, I2 = 71%). Therefore, to further explore possible sources of heterogeneity, sensitivity was analyzed. Galbraith diagram showed 1 study: Xie [40] might have a substantial impact on inhomogeneity (Figure 8). After exclusion of this study, we got no obvious heterogeneity (Figure 9, I2 = 0%, ). Combining the results of the two studies, the revised correction result indicated the improvement rate of food intake in the acupuncture set was still higher than the control set (Figure 9, RR: 1.17, 95% CI: 1.01∼1.36; ); the meta-analysis results were robust.

3.4.7. Improvement Rate of Lassitude Symptom

Two studies [30, 40] reported an improvement rate of lassitude symptom of 122 participants; I2 = 0% and suggested no obvious heterogeneity between the studies. Using the fixed-effects model, the pooled data showed that no marked difference existed between the acupuncture set and the control set in the improvement rate of lassitude symptom (Figure 10, RR: 1.01; 95% CI: 0.89∼1.14; ). Since , the divergence between both groups was not statistically distinct.

3.4.8. Serum Potassium

Two studies [29, 31] reported the serum potassium of 135 participants. With no obvious heterogeneity being seen (, I2 = 0%), the fixed-effects model was run for analysis. According to the results, indicated no marked divergence between the two groups in improving serum potassium (Figure 11, WMD: 0.11, 95% CI: −0.04∼0.25; ).

3.4.9. Length of Hospital Stay

Two studies [29, 35] were found to report the length of hospital stay in the therapeutic team and the control team. There was a moderate study heterogeneity (, I2 = 66%). Consequently, an analysis was conducted via the random-effects model. The results exhibited that , a remarkable difference between groups was observed, indicating that the hospital stays in the acupuncture group were less than conventional treatments in the control group (Figure 12, WMD: −3.78, 95% CI: −5.39∼−2.16; ), and the variance between both sets was statistically significant ().

3.4.10. Pregnancy Termination Rate

Two studies [29, 31] reported a pregnancy termination rate of 135 participants. There was no obvious heterogeneity (, I2 = 0%), so the fixed-effects model was used to perform further analysis. The results demonstrated that the pregnancy termination rate in the acupuncture group was lower than conventional interventions in controls (Figure 13, RR: 0.26, 95% CI: 0.09∼0.74; ), showing a statistically significant difference ().

3.4.11. Recurrence Rate

Only one study [35] amplified the relapse rates of the therapeutic set and the control set after the whole therapy. The random-effects model illustrated that , and the between-study difference was not statistically distinct, so the acupuncture set did not differ significantly from the control set concerning the recurrence rate (RR: 0.11, 95% CI: 0.01∼1.98; ).

3.4.12. Adverse Events Rate

One study [38] was found to report adverse events. In the acupuncture set, there was one skin rash case; in the control set, there were two cases of skin rash, three of dizziness, and three of facial flushing. Compared with the control set, the random-effects model suggested that the incidence of adverse events in the acupuncture group was lower (RR: 0.13, 95% CI: 0.02∼0.94; ). Since (), there was a marked divergence between both sets.

3.5. Publication Bias

According to the funnel plot, there was no significant asymmetry for the effective rate (Figure 14). In Egger’s test, the value of the effective rate of 0.08 () and the conversion rate of urine ketone of 0.322 () indicated no publication bias in the meta-analysis of the effective rate and the urinary ketone conversion rate. Because the number of included studies for other outcomes was too small (n < 5), the funnel plot was not performed.

3.6. Sensitivity Analysis

For outcomes without obvious heterogeneity, such as the effective rate, conversion rate of urine ketone, symptom improvement rate of nausea and vomiting, and lassitude, serum potassium, and pregnancy termination rate, sensitivity analyses were carried out through the method of conversion effect model. For studies with obvious heterogeneity, such as the improvement rate of food intake, the sensitivity analysis was performed by excluding individual studies. The same effects indicated the robustness of the combined result.

4. Discussion

Studies meeting inclusion criteria, from 1995 to 2020, have been incorporated into this meta-analysis to make evaluations on the outcome of acupuncture in the treatment of HG. Totally, 16 studies and 1043 patients (531 vs 512) were covered. According to this study, acupuncture was more effective than the conventional treatment of HG; it could better promote the conversion of the urinary ketone to improve ketonuria. In terms of symptoms, acupuncture seems to be more effective in reducing nausea and vomiting and increasing food intake. However, one study showed that there was no difference between acupuncture and conventional medication (metoclopramide infusion and oral vitamin B12 complex) in reducing the intensity of nausea and reducing the onset of vomiting. The reasons for the different results may be caused by the different focus of the outcomes, evaluation criteria, and intervention plans. In addition, the possibility could not be ruled out whether acupuncture and the medication (metoclopramide and vitamin B12 complex) had no difference in efficacy because the relationship between acupuncture and the medicine was unclear. However, it should also be noted that because the number of studies on the outcomes of symptoms improvement is too small (n < 3) and the sample size is small, the role of acupuncture in improving these symptoms needs more trials to verify. Furthermore, this meta-analysis uncovered that acupuncture seems to shorten the hospitalization time, but since only two studies mentioned this result, and the heterogeneity is moderate, which may be related to the severity of the disease, so whether acupuncture can shorten hospital stay needs further research. Besides, there were data showing that acupuncture manifested lower occurrence of adverse events and pregnancy termination. But also, because of the small number of included studies and the low quality of the evidence, further studies on the safety of acupuncture treatment are needed in the future. However, acupuncture does not seem to have any advantages in reducing recurrence and improving serum potassium and symptoms of lassitude. Due to the small number of included studies of secondary outcomes (n < 5), we must be cautious about their role in acupuncture. With the increase and improvement of future trials, the results may be reversed. In general, due to the low quality of the included studies and the potential bias risk, low evidence supports the positive effects of acupuncture in HG.

As one of the complementary therapies, acupuncture is common in the treatment of HG. Through the stimulation of meridians and acupuncture points, acupuncture can regulate qi-blood as well as yin-yang and improve the function of the viscera [43]. Although similar treatments, such as acupressure and hydro-acupuncture, are commonly used in HG, acupuncture still has its unique advantages. Acupuncture outperforms acupressure in the onset and duration of treatment. Acupressure requires prolonged (at least 8–12 hours) and correct use of the wristband to maintain curative effect [44]. Carlsson et al. observed that acupuncture could relieve vomiting in the treatment of HG within a few minutes, which may be associated with some neural substrate [45]. Besides, acupressure often solely selects Neiguan (PC6), the commonly used acupoint in treating HG, whereas acupuncture is more flexible, dialectically selecting acupoints according to individual conditions and the holistic situation. Moreover, Habek et al. found that acupuncture was superior to acupressure in treating HG, probably owing to the milder stimulation of acupressure and faster and more intense neurophysiological effects yielded by acupuncture [18]. In addition, acupuncture is often referred to as mind-body therapy. It has favorable effects on both mental and gastrointestinal psychosomatic disorders through the regulation of the autonomic nervous system [4648]. The role of acupuncture in reducing the anxiety and depression scores in patients with nausea during pregnancy has been reported previously [49]. As for hydroacupuncture therapy, although its efficacy on HG has been demonstrated to some extent [22], further research is required because of its considerable stimulation, significant pain, unclear adverse effects, and action mechanism. The mechanisms of acupuncture in the treatment of HG are gradually being explored and currently focus its antiemetic and gastrointestinal function. Many experiments have demonstrated the influence of acupuncture on the endogenous opioid system [50] as well as 5-hydroxytryptamine transmission [51] by activating 5-hydroxytryptamine and noradrenergic fibers, thereby affecting the afferent stimulation of the central nervous system to the vomiting center and reducing nausea and vomiting. In addition, it can not only regulate gastrointestinal motility by stimulating the reflexes of the vagus and sympathetic nerves [52, 53] but also affect gastric emptying via somatic visceral reflexes [54, 55] to modify nausea and vomiting. What is more, recent studies have uncovered that the use of acupuncture during pregnancy may be a safe treatment modality to mitigate discomfort [56, 57], with no report of severe negative events on mothers or newborns [58].

There are some strengths in this study. At present, there are systematic reviews on all interventions of HG, and the latest one only included 3 acupuncture trials published in 2018 [59]. But as far as we know, this study is the first systematic review and meta-analysis to comprehensively evaluate the effectiveness of acupuncture for HG without geographical restrictions. We mainly focus on the role of common forms of acupuncture, which reduces the possible variability of other acupuncture forms on the results and more accurately evaluates the effects of acupuncture in HG. We have also included the outcome indicators for acupuncture in HG as comprehensively as possible. Although the number of studies included in the secondary outcomes is small, we hope that this will provide more possibilities and references for future clinical research and practice. At present, acupuncture is a commonly used complementary therapy for HG. Our study specifically addresses this issue and supports that acupuncture may be used as a complementary and alternative therapy for HG.

In short, acupuncture is an effective approach for HG and has a great potential to mitigate ketonuria, ease nausea and vomiting, increase food intake, and shorten the hospital stay. There is some evidence that acupuncture may be utilized as a supplement and alternative to HG. However, the poor quality of the incorporated studies and potential publication bias can exert a certain impact on the results. For the better clinical application and promotion of acupuncture in the treatment of HG, more large-scale samples, multi-center, and top-quality RCTs are needed urgently. In the future, it is necessary to further study the relationship between acupuncture and conventional medication and acupuncture placebo to obtain the best clinical solution.

5. Limitations

This meta-analysis has demonstrated that acupuncture possesses favorable effects on HG. However, several limitations must be acknowledged. Firstly, 14 of the 16 included studies are Chinese, which tends to induce publication bias. Secondly, most of the included RCTs are small samples, and the number of studies included in the outcomes is small. Thirdly, since the particularity of acupuncture therapy, there are certain difficulties in the study of allocation hiding and blinding and there is a possibility of bias. The poor methodological quality, the flawed design of the incorporated research, and potential bias may disturb the accuracy of the results. Fourthly, the lack of uniformity in diagnostic and efficacy criteria and incomprehensive outcome indicators in the included studies may affect the precision of assessing the effectiveness of acupuncture treatment. Fifthly, due to the significant differences in acupoint selection and acupuncture stimulation, it is not conducive to unified data analysis. Sixthly, only one study [38] mentioned adverse event reports, and the safety reports were insufficient. Lastly, all studies were short-term efficacy evaluations, with no follow-up, and further research should be conducted to examine whether acupuncture has sustained effects on HG.

Data Availability

The data used to support the findings of this study are included within the article. Also, the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

Acknowledgments

The authors would like to thank Dr. Yiling Bai of Chengdu University of Traditional Chinese Medicine for her help with this article.

Supplementary Materials

Table S1: the checklist of PRISMA guidelines. (Supplementary Materials)

References

  1. M. Koot, R. Boelig, J. van‘t Hooft et al., “Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 125, no. 12, pp. 1514–1521, 2018. View at: Publisher Site | Google Scholar
  2. M. F. G. Verberg, D. J. Gillott, N. Al-Fardan, and J. G. Grudzinskas, “Hyperemesis gravidarum, a literature review,” Human Reproduction Update, vol. 11, no. 5, pp. 527–539, 2005. View at: Publisher Site | Google Scholar
  3. M. S. Fejzo, J. Trovik, I. J. Grooten et al., “Nausea and vomiting of pregnancy and hyperemesis gravidarum,” Nature Reviews Disease Primers, vol. 5, no. 1, p. 62, 2019. View at: Publisher Site | Google Scholar
  4. J. Trovik and Å. Vikanes, “Hyperemesis gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering,” Israel Journal of Health Policy Research, vol. 5, no. 1, p. 43, 2016. View at: Publisher Site | Google Scholar
  5. L. Fiaschi, C. Nelson-Piercy, J. Gibson, L. Szatkowski, and L. J. Tata, “Adverse maternal and birth outcomes in women admitted to hospital for hyperemesis gravidarum: a population-based cohort study,” Paediatric and Perinatal Epidemiology, vol. 32, no. 1, pp. 40–51, 2018. View at: Publisher Site | Google Scholar
  6. P. M. Mullin, C. Ching, F. Schoenberg et al., “Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, no. 6, pp. 632–636, 2012. View at: Publisher Site | Google Scholar
  7. N. Mitchell-Jones, I. Gallos, J. Farren, A. Tobias, C. Bottomley, and T. Bourne, “Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 124, no. 1, pp. 20–30, 2017. View at: Publisher Site | Google Scholar
  8. J. Christodoulou-Smith, J. I. Gold, R. Romero et al., “Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 24, no. 11, pp. 1307–1311, 2011. View at: Publisher Site | Google Scholar
  9. C. Dean, K. Bannigan, and J. Marsden, “Reviewing the effect of hyperemesis gravidarum on women’s lives and mental health,” British Journal of Midwifery, vol. 26, 2018. View at: Publisher Site | Google Scholar
  10. Z. J. Wang, J. Qian, and J. Wu, “Preliminary study on hyperemesis gravidarum complicated with abnormal thyroid function,” Journal of Reproductive Medicine, vol. 24, no. 8, pp. 618–621, 2015. View at: Google Scholar
  11. Z. X. Yang, P. D. Chen, F. Liu et al., “Clinical study strategies of acupuncture treatment of hyperemesis gravidarum,” Journal of Liaoning University of Traditional Chinese Medicine, vol. 17, no. 12, pp. 9–11, 2015. View at: Google Scholar
  12. C. R. Dean, C. M. Bruin, M. E. O’Hara et al., “The chance of recurrence of hyperemesis gravidarum: a systematic review,” European Journal of Obstetrics & Gynecology and Reproductive Biology: X, vol. 5, p. 100105, 2020. View at: Publisher Site | Google Scholar
  13. I. J. Grooten, W. J. Den Hollander, T. J. Roseboom et al., “Helicobacter pylori infection: a predictor of vomiting severity in pregnancy and adverse birth outcome,” American Journal of Obstetrics and Gynecology, vol. 216, pp. 512.e1–512.e9, 2017. View at: Publisher Site | Google Scholar
  14. M. S. Fejzo, S. A. Ingles, M. Wilson et al., “High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 141, no. 1, pp. 13–17, 2008. View at: Publisher Site | Google Scholar
  15. H. K. Kjeldgaard, M. Eberhard-Gran, J. Š. Benth, H. Nordeng, and Å. V. Vikanes, “History of depression and risk of hyperemesis gravidarum: a population-based cohort study,” Archives of Women’s Mental Health, vol. 20, no. 3, pp. 397–404, 2017. View at: Publisher Site | Google Scholar
  16. R. Yang, J. M. Hu, L. Piao et al., “The new development of research on related risk factors of hyperemesis gravidarum,” Maternal and Child Health Care of China, vol. 31, no. 10, pp. 2227–2229, 2016. View at: Google Scholar
  17. K. Austin, K. Wilson, and S. Saha, “Hyperemesis gravidarum,” Nutrition in Clinical Practice, vol. 34, no. 2, pp. 226–241, 2019. View at: Publisher Site | Google Scholar
  18. D. Habek, A. Barbir, J. Č. Habek, D. Jančuliak, and M. Bobić-Vuković, “Success of acupuncture and acupressure of the Pc 6 acupoint in the treatment of hyperemesis gravidarum,” Complementary Medicine Research, vol. 11, no. 1, pp. 20–23, 2004. View at: Publisher Site | Google Scholar
  19. I. Neri, G. Allais, P. Schiapparelli, I. Blasi, C. Benedetto, and F. Facchinetti, “Acupuncture versus pharmacological approach to reduce Hyperemesis gravidarum discomfort,” Minerva Ginecologica, vol. 57, pp. 471–475, 2005. View at: Google Scholar
  20. M. E. van Stuijvenberg, I. Schabort, D. Labadarios, and J. T. Nel, “The nutritional status and treatment of patients with hyperemesis gravidarum,” American Journal of Obstetrics and Gynecology, vol. 172, no. 5, pp. 1585–1591, 1995. View at: Publisher Site | Google Scholar
  21. P. C. Tan, M. J. Norazilah, and S. Z. Omar, “Dextrose saline compared with normal saline rehydration of hyperemesis gravidarum,” Obstetrics & Gynecology, vol. 121, no. 2, pp. 291–298, 2013. View at: Publisher Site | Google Scholar
  22. X. Y. Lin, Q. X. Shen, and L. X. Zhuang, “Clinical efficacy of acupoint injection in treating hyperemesis gravidarum: a meta-analysis,” Journal of Clinical Acupuncture and Moxibustion, vol. 35, pp. 62–67, 2019. View at: Google Scholar
  23. H. Tada, M. Fujita, M. Harris et al., “Neural mechanism of acupuncture-induced gastric relaxations in rats,” Digestive Diseases and Sciences, vol. 48, no. 1, pp. 59–68, 2003. View at: Publisher Site | Google Scholar
  24. J. Wise, “Women with nausea and vomiting in pregnancy should be offered more support, say RCOG guidelines,” BMJ, vol. 353, p. i3509, 2016. View at: Publisher Site | Google Scholar
  25. K. Campbell, H. Rowe, H. Azzam, and C. A. Lane, “The management of nausea and vomiting of pregnancy,” Journal of Obstetrics and Gynaecology Canada, vol. 38, no. 12, pp. 1127–1137, 2016. View at: Publisher Site | Google Scholar
  26. M. Erick, J. T. Cox, and K. M. Mogensen, “ACOG practice bulletin 189: nausea and vomiting of pregnancy,” Obstetrics & Gynecology, vol. 131, no. 5, p. 935, 2018. View at: Publisher Site | Google Scholar
  27. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009. View at: Publisher Site | Google Scholar
  28. J. P. T. Higgins, S. G. Thompson, J. J. Decks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” BMJ, vol. 327, no. 7414, pp. 557–560, 2003. View at: Publisher Site | Google Scholar
  29. L. H. Jin and D. X. Hu, “Clinical observation on filiform needling combined with symptomatic and supportive therapy for 20 cases of intractable hyperemesis gravidarum,” Journal of Traditional Chinese Medicine, vol. 55, no. 11, pp. 939–941, 2014. View at: Google Scholar
  30. W. J. Ma, S. Y. Cui, Y. Ning et al., “Observation on the therapeutic effect of lingnan flying needling combined with symptomatic supportive therapy in the treatment of hyperemesis gravidarum,” Guangming Journal of Chinese Medicine, vol. 35, no. 2, pp. 228–230, 2020. View at: Google Scholar
  31. R. Y. Wang, “Clinical observation on the treatment of hyperemesis gravidarum by acupoint method,” Shanxi Medical Journal, vol. 37, no. 2, pp. 135-136, 2008. View at: Google Scholar
  32. J. Z. Ma and L. P. Meng, “Observation on the therapeutic effect of 30 cases of hyperemesis pregnancy treated with the method of connection between back-shu and from-mu points prescription,” Journal of Sichuan of Traditional Chinese Medicine, vol. 31, no. 11, pp. 134-135, 2013. View at: Google Scholar
  33. R. Zhao and L. J. Qiao, “Clinical observation of acupuncture at the eight confluent points plus acupoint sticking for hyperemesis gravidarum,” Shanghai Journal of Acupuncture and Moxibustion, vol. 37, no. 8, pp. 891–894, 2018. View at: Google Scholar
  34. X. Zhang, “Clinical observation of acupuncture combined with psychological counseling in treating 31 cases of hyperemesis gravidarum,” Hunan Journal of Traditional Chinese Medicine, vol. 29, no. 6, pp. 74-75, 2013. View at: Google Scholar
  35. L. Yan, R. R. Liu, F. S. Ji et al., “Observation on the curative effect of acupuncture therapy on hyperemesis gravidarum,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 29, no. 21, pp. 973–976, 2012. View at: Google Scholar
  36. Y. Xu, W. Z. Huang, Q. W. Li et al., “Clinical observation of acupuncture combined with moxibustion in the treatment of hyperemesis gravidarum with spleen and stomach weakness syndrome type,” Journal of Frontiers of Medicine, vol. 5, no. 10, pp. 341-342, 2015. View at: Google Scholar
  37. Y. L. Sun and L. Cui, “The role of acupuncture in the treatment of hyperemesis gravidarum,” Journal of Jiangsu University (Medicine Edition), vol. 5, no. 3, p. 249, 1995. View at: Google Scholar
  38. R. Yang, “Analysis of the efficacy and safety of acupuncture in the auxiliary treatment of hyperemesis gravidarum,” Health Horizon, vol. 7, p. 92, 2019. View at: Google Scholar
  39. Q. Zhong, “Clinical observation of acupuncture and moxibustion in the treatment of hyperemesis gravidarum,” Inner Mongolia Journal of Traditional Chinese Medicine, vol. 36, no. 14, pp. 120-121, 2017. View at: Google Scholar
  40. H. Y. Xie, “Clinical effects of acupuncture and medicine combination on urine ketone of hyperemesis gravidarum,” Nanjing University of ChineseTraditional Medicine, Nanjing, China, 2006, Master thesis. View at: Google Scholar
  41. Z. N. Mao and C. E. Liang, “Observation on therapeutic effect of acupuncture on hyperemesis gravidarum,” Chinese Acupuncture & Moxibustion, vol. 29, no. 12, pp. 973–976, 2009. View at: Google Scholar
  42. H. H. Zhang, “Observation on therapeutic effect of acupuncture and moxibustion on hyperemesis gravidarum,” Chinese Acupuncture & Moxibustion, vol. 25, no. 7, pp. 469-470, 2005. View at: Google Scholar
  43. Y. R. Chen, “Clinical application of acupuncture and moxibustion therapy for treatment of morning sickness of pregnant women,” Journal of Guangzhou University of Traditional Chinese Medicine, vol. 37, 2020. View at: Google Scholar
  44. F. Tara, H. Bahrami-Taghanaki, M. Amini Ghalandarabad et al., “The effect of acupressure on the severity of nausea, vomiting, and retching in pregnant women: a randomized controlled trial,” Complementary Medicine Research, vol. 27, no. 4, pp. 252–259, 2020. View at: Publisher Site | Google Scholar
  45. C. P. O. Carlsson, P. Axemo, A. Bodin et al., “Manual acupuncture reduces hyperemesis gravidarum,” Journal of Pain and Symptom Management, vol. 20, no. 4, pp. 273–279, 2000. View at: Publisher Site | Google Scholar
  46. R. B. K. Rohrböck, J. Hammer, H. Vogelsang, N. J. Talley, and H. F. Hammer, “Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: a study in health and IBS,” The American Journal of Gastroenterology, vol. 99, no. 10, pp. 1990–1997, 2004. View at: Publisher Site | Google Scholar
  47. Schneider, S. Enck, Weiland, and Bagheri, “Acupuncture treatment in irritable bowel syndrome,” Gut, vol. 55, pp. 649–654, 2006. View at: Publisher Site | Google Scholar
  48. X.-y. Yang, N.-b. Yang, F.-f. Huang, S. Ren, and Z.-j. Li, “Effectiveness of acupuncture on anxiety disorder: a systematic review and meta-analysis of randomised controlled trials,” Annals of General Psychiatry, vol. 20, no. 1, p. 9, 2021. View at: Publisher Site | Google Scholar
  49. B. Knight, C. Mudge, S. Openshaw, A. White, and A. Hart, “Effect of acupuncture on nausea of pregnancy,” Obstetrics & Gynecology, vol. 97, no. 2, pp. 184–188, 2001. View at: Publisher Site | Google Scholar
  50. J. S. Han and L. Terenius, “Neurochemical basis of acupuncture analgesia,” Annual Review of Pharmacology and Toxicology, vol. 22, no. 1, pp. 193–220, 1982. View at: Publisher Site | Google Scholar
  51. C. Takeshige, T. Sato, T. Mera, T. Hisamitsu, and J. Fang, “Descending pain inhibitory system involved in acupuncture analgesia,” Brain Research Bulletin, vol. 29, no. 5, pp. 617–634, 1992. View at: Publisher Site | Google Scholar
  52. M.-J. Lu, Z. Yu, Y. He, Y. Yin, and B. Xu, “Electroacupuncture at ST36 modulates gastric motility via vagovagal and sympathetic reflexes in rats,” World Journal of Gastroenterology, vol. 25, no. 19, pp. 2315–2326, 2019. View at: Publisher Site | Google Scholar
  53. Z. G. Sun, Y. L. Pi, J. Zhang, M. Wang, J. Zou, and W. Wu, “Effect of acupuncture at ST36 on motor cortical excitation and inhibition,” Brain and Behavior, vol. 9, Article ID e01370, 2019. View at: Publisher Site | Google Scholar
  54. K. Streitberger, J. Ezzo, and A. Schneider, “Acupuncture for nausea and vomiting: an update of clinical and experimental studies,” Autonomic Neuroscience, vol. 129, no. 1-2, pp. 107–117, 2006. View at: Publisher Site | Google Scholar
  55. D. Zou, W. H. Chen, K. Iwakiri, R. Rigda, M. Tippett, and R. H. Holloway, “Inhibition of transient lower esophageal sphincter relaxations by electrical acupoint stimulation,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 289, no. 2, pp. G197–G201, 2005. View at: Publisher Site | Google Scholar
  56. H. Y. Moon, M. r. Kim, D. S. Hwang et al., “Safety of acupuncture during pregnancy: a retrospective cohort study in Korea,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 127, no. 1, pp. 79–86, 2020. View at: Publisher Site | Google Scholar
  57. N. E. Foster, A. Bishop, B. Bartlam et al., “Evaluating Acupuncture and Standard carE for pregnant women with Back pain (EASE Back): a feasibility study and pilot randomised trial,” Health Technology Assessment, vol. 20, no. 33, pp. 1–236, 2016. View at: Publisher Site | Google Scholar
  58. A. Einion, “The management of nausea and vomiting of pregnancy and hyperemesis gravidarum,” The Practising Midwife, vol. 19, pp. 33–35, 2016. View at: Google Scholar
  59. S. Kannan and S. Gowri, “Interventions for treating hyperemesis gravidarum: a network meta-analysis of randomized clinical trials,” Journal of Maternal Fetal & Neonatal Medicine, vol. 33, pp. 1–181, 2018. View at: Google Scholar

Copyright © 2021 Haizhen Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views308
Downloads197
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.